Skip to content
DataLookout
Menu

ADONeSSNCT07930663

ADONeSS - Study of Autoimmune Diseases of the Nervous System

StatusEnrolling by Invitation
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Increase in overall knowledge and level of understanding regarding autoimmune disorders of the nervous system
Timeframe: From study start (September 2015) to study completion (Anticipated Aug 2028), assessed continuously through retrospective review of medical records and prospective collection of clinical and research data (approximately 13 years).

Arms and interventions

Potential participants will be identified by clinical care team.

1. Patients attending Walton Centre FT with ADONeS. 2. Capable of informed consent 3. Non-written consent will be accepted from those who want to participate in the study and are able to grant informed consent yet are physically unable to give written consent due to their disability. At least one witness other than the clinician providing information for informed consent will be required to countersign the consent form to state that they have witnessed the participants' non-written consent.